TGFB1 and glaucoma: Another study on New Zealand White rabbits suggests that topical Infliximab effectively suppresses the subconjunctival wound healing response after experimental glaucoma filtration surgery, reducing the MNC (inflammatory mononuclear cells) and fibroblast numbers and immunostaining intensities of TGF-β, FGF-β, and PDGF [29].